版本:
中国

BRIEF-Sonoma Pharmaceuticals says receives two new UAE regulatory approvals, Pediacyn® for atopic dermatitis and Epicyn® for scar management

April 12 Sonoma Pharmaceuticals Inc

* Sonoma Pharmaceuticals - receives two new united arab emirates regulatory approvals: Pediacyn® for atopic dermatitis and Epicyn® for scar management

* Sonoma Pharmaceuticals - both offerings, based upon Sonoma's patented Microcyn® Technology hypochlorous acid, will be supplied by MicroSafe Group to UAE beginning in may 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐